most notably Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center. The CDD bridges the gap between academic research and pharmaceutical discovery and provides researchers ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

and Critical Care in the FDA’s Center for Drug Evaluation and Research, per the press release. “This is a major step forward for patients with obstructive sleep apnea.” The FDA conducted two ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...

These initiatives represent a way to accelerate access to treatments that have historically faced longer regulatory pathways.

The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because ...